Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...
Executives from Oric Pharmaceuticals (NASDAQ:ORIC) used a conference discussion to highlight near-term clinical catalysts for ...
Prostate cancer may spread to your bones, causing pain and fractures. Jaundice can indicate that prostate cancer has spread to the liver. A chronic cough or shortness of breath may signal prostate ...
CHICAGO – Drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There’s even a “uni-drug” that may fight many forms of the ...
CHICAGO — Newer drugs are substantially improving the chances of survival for some people with hard-to-treat forms of lung, breast and prostate cancer, doctors reported at the world’s largest cancer ...
Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
More people die of lung cancer each year than breast, colon, and prostate cancers combined. One particularly lethal form of the disease is lung adenocarcinoma or LUAD, which afflicts both smokers and ...
More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results